This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: Ibutamoren
MK-677 (Ibutamoren) is an orally active non-peptide growth hormone secretagogue that mimics ghrelin's action at the GHS-R1a receptor. Despite being called a peptide by the community, it's technically a small molecule.
MK-677 acts as a potent ghrelin mimetic at the growth hormone secretagogue receptor 1a. Oral bioavailability of ~60% enables once-daily dosing, producing sustained elevations of GH and IGF-1 levels. Unlike injectable GHRH/GHRP combos, MK-677 raises baseline GH levels rather than producing discrete pulses, leading to higher average IGF-1 over 24 hours. It also promotes slow-wave sleep through hypothalamic mechanisms, with clinical trials confirming improved sleep architecture.
MK-677 acts as a potent ghrelin mimetic at the growth hormone secretagogue receptor 1a. Oral bioavailability of ~60% enables once-daily dosing, producing sustained elevations of GH and IGF-1 levels. Unlike injectable GHRH/GHRP combos, MK-677 raises baseline GH levels rather than producing discrete pulses, leading to higher average IGF-1 over 24 hours. It also promotes slow-wave sleep through hypothalamic mechanisms, with clinical trials confirming improved sleep architecture.
MK-677 (Ibutamoren) is an orally active non-peptide growth hormone secretagogue that mimics ghrelin's action at the GHS-R1a receptor. Despite being called a peptide by the community, it's technically a small molecule. Extensive clinical data exists from Merck's Phase 2 trials showing significant GH and IGF-1 elevation with daily oral dosing. Research covers body composition, bone density, sleep, and cognition.
IUPAC Name
2-amino-2-methyl-N-[1-(methylsulfonylmethyl)-2-(1-methylpropyl)-3-(1H-indol-3-ylmethyl)...] (complex structure)
CAS Number
159634-47-6
Molecular Formula
C27H36N4O5S
Molecular Mass
528.67 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Active cancer or history of cancer. Diabetes or pre-diabetes (worsens insulin resistance). History of pituitary tumors. Intracranial hypertension. Pregnancy or breastfeeding. Children with open growth plates (unless under medical supervision).
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$49.99
$0.0667
1
1
liquid
Growth Hormone / IGF-1 Axis
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid GHRH analog with four amino acid substitutions that extend its half-life from under 2 minutes to approximately 30 minutes.
Growth Hormone / IGF-1 Axis
CJC-1295 with DAC uses a Drug Affinity Complex linker (maleimidopropionic acid) that forms a permanent covalent bond with serum albumin after injection, extending the half-life to 6β8 days.
Growth Hormone / IGF-1 Axis
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland.
Growth Hormone / IGF-1 Axis
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue and one of the original GHRPs studied.
Growth Hormone / IGF-1 Axis
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP.
Growth Hormone / IGF-1 Axis
IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension.
View Full Dosage Guide β
Protocols, calculator & safety for MK-677 (Ibutamoren)
45 PubMed studies
Data Completeness
100%Research Credibility
Half-Life
4β6 hours (effects on GH last ~24 hours due to IGF-1 elevation)
Molecular Weight
528.67 g/mol
Administration
Oral
CAS Number
159634-47-6
Trial Phase
Phase 2
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
MK-677 (Ibutamoren) is an orally active non-peptide growth hormone secretagogue that mimics ghrelin's action at the GHS-R1a receptor. Despite being called a peptide by the community, it's technically a small molecule. Extensive clinical data exists from Merck's Phase 2 trials showing significant GH and IGF-1 elevation with daily oral dosing. Research covers body composition, bone density, sleep, and cognition.
MK-677 (Ibutamoren) is available in liquid form.
Prices start at $49.99 across 1 verified vendor.
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
Growth Hormone / IGF-1 Axis
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid GHRH analog with four amino acid substitutions that extend its half-life from under 2 minutes to approximately 30 minutes.
Growth Hormone / IGF-1 Axis
CJC-1295 with DAC uses a Drug Affinity Complex linker (maleimidopropionic acid) that forms a permanent covalent bond with serum albumin after injection, extending the half-life to 6β8 days.
Growth Hormone / IGF-1 Axis
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland.
Growth Hormone / IGF-1 Axis
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue and one of the original GHRPs studied.
Growth Hormone / IGF-1 Axis
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP.
Growth Hormone / IGF-1 Axis
IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension.